What is NDC 69238-1420?

69238-1420 is the product NDC for Silodosin, Silodosin 8 mg/1 capsule, listed with the FDA by Amneal Pharmaceuticals NY LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

Amneal Pharmaceuticals NY LLC, NDC labeler code 69238. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Silodosin?

28 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Silodosin NDC 69238-1420 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)69238-1420Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69238-1420Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69238-1420-3	6923814200369238142003	30 CAPSULE in 1 BOTTLE (69238-1420-3)Marketed from Dec 3, 2018
69238-1420-9	6923814200969238142009	90 CAPSULE in 1 BOTTLE (69238-1420-9)Marketed from Dec 3, 2018

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Silodosin
Generic name (nonproprietary): silodosin
Active ingredients: Silodosin — 8 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Amneal Pharmaceuticals NY LLCNDC labeler code 69238
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209745
Marketing start: Dec 3, 2018
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic alpha-Antagonists (Mechanism)
Identifiers: Product ID 69238-1420_36fb79b1-8d84-4afa-b26c-78a83394140dSPL ID 36fb79b1-8d84-4afa-b26c-78a83394140dSPL set ID de619e27-9384-4b86-abdc-de0557cd39e8RxCUI 809477, 826612UNII CUZ39LUY82
Pharmacologic class: alpha-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469238142003 followed by a unit qualifier and the quantity

Package 69238-1420-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 15, 2026.

Indications (excerpt from the label)

Silodosin, a selective alpha-1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see Clinical Studies (14 ) ] . Silodosin capsules are not indicated for the treatment of hypertension. Silodosin, an alpha-1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). Silodosin capsules are not indicated for the treatment of hypertension. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 69238-1420

What is NDC 69238-1420?: 69238-1420 is the product NDC for Silodosin, Silodosin 8 mg/1 capsule, listed with the FDA by Amneal Pharmaceuticals NY LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Silodosin.
What is the active ingredient?: Silodosin.
Who is the labeler?: Amneal Pharmaceuticals NY LLC, NDC labeler code 69238. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Silodosin?: 28 other product NDCs are listed under this name. See all Silodosin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Silodosin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Silodosin	Silodosin 4 mg/1	CapsuleOral	Bryant Ranch Prepack	72162-2446	72162-2446-03
Silodosin	Silodosin 8 mg/1	CapsuleOral	Bryant Ranch Prepack	72162-2447	72162-2447-0372162-2447-09
Silodosin	Silodosin 4 mg/1	CapsuleOral	Creekwood Pharmaceuticals LLC	82619-113	82619-0113-01
Silodosin	Silodosin 8 mg/1	CapsuleOral	Creekwood Pharmaceuticals LLC	82619-114	82619-0114-0182619-0114-02
Silodosin	Silodosin 4 mg/1	CapsuleOral	AvKARE	42291-777	42291-0777-30
Silodosin	Silodosin 8 mg/1	CapsuleOral	AvKARE	42291-778	42291-0778-90
Silodosin	Silodosin 4 mg/1	CapsuleOral	Camber Pharmaceuticals, Inc.	31722-635	31722-0635-3031722-0635-3131722-0635-90+1 more
Silodosin	Silodosin 8 mg/1	CapsuleOral	Camber Pharmaceuticals, Inc.	31722-636	31722-0636-3031722-0636-3131722-0636-90+1 more
Silodosin	Silodosin 4 mg/1	CapsuleOral	Alembic Pharmaceuticals Limited	46708-405	46708-0405-3046708-0405-9046708-0405-91
Silodosin	Silodosin 8 mg/1	CapsuleOral	Alembic Pharmaceuticals Limited	46708-406	46708-0406-3046708-0406-9046708-0406-91

All 29 Silodosin NDCs

Other NDCs under ANDA 209745

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209745
Product	Strength	Form · route	Labeler	Product NDC
Silodosin	Silodosin 4 mg/1	CapsuleOral	AvKARE	42291-777
Silodosin	Silodosin 8 mg/1	CapsuleOral	AvKARE	42291-778
Silodosin	Silodosin 8 mg/1	CapsuleOral	Amneal Pharmaceuticals NY LLC	60219-1420
Silodosin	Silodosin 4 mg/1	CapsuleOral	Amneal Pharmaceuticals NY LLC	60219-1421
Silodosin	Silodosin 4 mg/1	CapsuleOral	Amneal Pharmaceuticals NY LLC	69238-1421